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Cancer and How the Community Responses to Nutrition Factors in 
Developing Country Nepal
Bohara, Amrit B. 
Community Health and Environmental Society, Kathmandu, Nepal
Objective: The prevalence rate of cancer in Nepal is high. Due to pov-
erty and illiteracy, ost of the patient come to the hospital in later stage. 
smoking and indoor pollution is major problem in urban and rural 
community of Nepal. This study was to ﬁnd out the epidemiology and 
prevalence of lung cancer in community. Methods:A case-control study 
involving interviews and clinical reports with 764 patients with lung 
cancer and 795 population-based controls was conducted in different 
part of Nepal, where mortality rates are high among men and women
Results: Cigarette smoking was found to be the principal cause of 
lung cancer in this population, accounting for 55% of the lung cancers 
in males and 37% in females. The attributable risk percentage among 
females is high compared to elsewhere in Nepal, largely because of a 
higher prevalence of smoking with local made alcohol among women 
and poor nutrition diet. After adjustment for smoking, there were 
also signiﬁcant increases in lung-cancer risk associated with several 
measures of exposure to air pollutants. Risks were twice as high among 
those who reported smoky outdoor environments, and increased in 
proportion to years of sleeping on beds heated by coal-burning stoves 
(chulo), and to an overall index of indoor air pollution. Threefold 
increase in lung cancer risk was found among men industrial occupa-
tion. The associations with both smoking and indoor air-pollution were 
stronger for squamous cell and small cell carcinomas than for adeno-
carcinoma of the lung. The patient intakes mostly smoked food and 
having poor vegetables and fruits regularly. 
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Genetic polymorphisms of metabolizing enzymes involved 
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metalloproteinase-1 in relation to lung cancer in Northern 
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Background: Lung cancer is a major cause of cancer-related death in 
developed countries and the incidence of this type of cancer is increas-
ing in developing countries. In Thailand, cancer incidences greatly 
differ from region to region, and in the Northern region lung cancer 
is the most frequent. Although the geographical variability in cancer 
patterns reﬂects exposure of the population to different environmental 
risk factors unique to the different regions, a possible role of genetic 
polymorphism as an individual risk modiﬁer for lung cancer has been 
addressed. In this study the polymorphisms of the well-investigated ge-
netic susceptibility genes, including cytochrome P450 (CYP1A1MspI, 
CYP2E1DraI, CYP2E1PstI), glutathione S-transferase (GSTM1, 
GSTT1) myeloperoxidase (MPO) and matrix metalloproteinase-1 
(MMP-1) in relations to lung cancer in the Northern Thai population 
was investigated. 
Methods: In 62 cases (39 males, 23 females) and 75 controls (31 
males, 44 females) polymorphisms were examined by multiplex-
PCR for GSTM1 and GSTT1, and by PCR-RFLP for CYP1A1MspI, 
CYP2E1DraI, CYP2E1PstI, MPO(-463G/A) and MMP-1(-1607 
1G/2G). Mean (SD) age was 59.2 (9.91) and 56.4 (13.7) years in the 
cases and controls, respectively.
Results: The observed allele frequencies of all of the genes studied 
were within the range previously described for the Asian population. 
The overall analysis showed that polymorphisms of all the genes 
studied were not signiﬁcantly associated with an increase risk of lung 
cancer. The risk of lung cancer was further examined by stratiﬁcation 
with smoking status and the odds ratios were calculated by logistic re-
gression with wild-type genotype as the reference group for non-smok-
ers and adjusted for age and gender. Among non-smokers, GSTM1 
null genotype signiﬁcantly increased the risk of lung cancer among 
non-smokers (OR=15.6, 95%-CI: 1.61-142.8). None of the other poly-
morphisms showed any signiﬁcant impact on lung cancer risk. Among 
smokers, odds ratio in smokers with GSTM1 null genotype (OR=52.5, 
95%-CI: 5.13-537.8) was higher than those carrying GSTM1 positive 
genotype (OR=41.4, 95%-CI: 4.59-376.1). Although variant alleles of 
MPO and MMP-1 did not show any impact on lung cancer risk in non-
smokers, it was found that odds ratio in smokers with MPO homozy-
gous variants (A/A) or heterozygous variants (A/G) (OR=12.46, 95%-
CI: 3.02-51.32) and smokers with MMP homozygous variants (2G/2G) 
(OR=7.49, 95%-CI: 2.20-25.42) was signiﬁcantly elevated compared 
to smokers who carried wild-type genotype of both genes, respectively 
(OR=6.60, 95%-CI: 2.41-18.07 and OR=2.98, 95%-CI: 0.60-14.67). 
This induction of OR may indicate a joint effect of the interaction be-
tween tobacco smoking and the MPO and MMP-1 polymorphism.
Conclusion: Our preliminary results indicate that polymorphisms of 
the GSTM1, MPO or MMP-1 have a modifying effect on smoking and 
lung cancer risk in the Northern Thai population; however, a larger 
sample population is necessary to conﬁrm our ﬁndings. 
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A retrospective study of patients with advanced non-small cell lung 
cancer and malignant pleural effusion.
Karrim, Juliana; Hwang, Jimmy; Jahan, Thierry; Jablons, David; 
Dubey, Sarita 
University of California, San Francisco, CA, USA
Background: Prior studies of patients with non-small cell lung cancer 
(NSCLC) have shown that those diagnosed with stage IIIB with pleural 
effusion (PE) have a worse prognosis than those without PE. We plan 
to further analyze the characteristics of 4 subgroups of patients with 
advanced stage non-small cell lung cancer.
Method: Data was collected retrospectively from medical records of 
patients identiﬁed through the cancer registry. All patients identiﬁed 
had a diagnosis of NSCLC stage IIIB and IV, and were seen at Univer-
sity of California, San Francisco, between years 2000-2004. Statistical 
studies were done to ﬁnd associations between baseline characteristics 
and survival. Survival analysis was calculated by Kaplan Meier meth-
od. Cox proportional hazards regression model was used to conﬁrm the 
signiﬁcance of each prognostic factor selected by univariate analysis. 
The Institutional Review Board approved this study. 
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Result: There were total of 339 patients: 158 females and 181 males. 
33 of 107 (30.8%) patients with stage IIIB had documented malignant 
PE, while 31 of 232 (13.4%) patients with stage IV had malignant PE 
(p=<0.01). The median survivals for the 4 subgroups of patients: stage 
IIIB without PE, IIIB with PE, IV without PE and IV with PE were 27 
mo, 6 mo, 10 mo and 7 mo respectively. The survival for stage IIIB 
without PE was statistically signiﬁcantly different from the other three 
subgroups (p=<0.0001). Median survival was 10 months for females 
and 7 months for males (p=0.001).
In univariate analysis, age, histology, family history, menopausal status, 
ethnicity, and smoking history were not signiﬁcant independent prog-
nostic factors. 
There were no signiﬁcant relationships between stage and age, gender, 
or histology. Similarly, there were no associations between family his-
tory and age at diagnosis or histology. 
Conclusion: Malignant PE is more commonly seen with IIIB than IV 
NSCLC, and is an independent prognostic discriminant for survival. 
Survivals of patients with PE in both IIIB and IV are similar, and a 
non-signiﬁcant trend suggests a worse prognosis in comparison to pa-
tients with IV without PE. The small sample size may have contributed 
to the lack of statistically signiﬁcant result. Patients with NSCLC and 
malignant PE could be categorized separately in the staging system if 
these results are statistically conﬁrmed by future studies.
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Distinctive characteristics of non-small cell lung cancer (NSCLC) 
in the young: Washington University experience
Subramanian, Janakiraman; Velcheti, Vamsidhar; Goodgame, Boone; 
Gao, Feng; Baggstrom, Maria; Govindan, Ramaswamy 
St. Louis, MO, USA
Background: NSCLC predominantly affects patients in their sixth 
and seventh decades of life. It is unclear whether the presentation and 
outcomes are different in the younger (deﬁned as age ≤ 40 years at the 
time of diagnosis) when compared with older patients (age > 40).
Methods: We reviewed the demographic, clinical and pathologic data 
of all patients diagnosed with NSCLC at Washington University School 
of Medicine-Siteman Cancer Center from 1990 to 2005.
Results: 6118 patients with NSCLC were identiﬁed and among them 
6010 were > 40 years and 108 were ≤ 40 years of age at the time of 
diagnosis. The proportion of women in the younger group was 53.7% 
vs. 43.6% in the older group (p = 0.03). The distribution of stages I, 
II, III and IV in the younger group was 14%, 7.5%, 34.6% and 43.9% 
as compared to 28.9%, 7.8%, 29.8% & 33.5% in the older group (p = 
0.006). Adenocarcinoma was the most common histology in the young-
er group compared to the older group (53.7% vs. 38.1%, p<0.001). 
Squamous cell carcinoma was less common in the younger vs. older 
group (15.7% vs. 29.9%, p<0.001). The proportion of younger patients 
diagnosed with brain metastasis at presentation was 18.5% vs. 10% in 
the older patients (p = 0.004). No signiﬁcant differences were detected 
for metastases to the other sites. The 5-year survival was higher in the 
younger group for each stage, but reached statistical signiﬁcance only 
in stage I disease, likely because of the small sample size (see table).
Conclusion: Lung cancer in younger patients is characterized by 
higher proportion of women, adenocarcinoma histology, stage IV dis-
ease, brain metastases at presentation and better overall survival when 
compared to older patients.
Table. Stage speciﬁc 5-year survival
 Age ≤ 40 Age ≤ 40 Age > 40 Age > 40 p value
 N
5 yr survival 
(%)
N
5 yr survival 
(%)
 
Stage I 15 85 1698 45 0.01
Stage II 8 64 469 31 0.20
Stage III 37 20 1789 12 0.13
Stage IV 47 9 2019 2 0.052
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Characteristics of non-small cell lung cancer in patients under 40: 
a National Cancer Database (NCDB) Analysis 1998-2004
Velcheti, Vamsidhar; Chitneni, Pooja; Goodgame, Boone; 
Morgensztern, Daniel; Gao, Feng; Baggstrom, Maria; Govindan, 
Ramaswamy 
Washington University, St Louis, MO, USA
Background: The median age of patients presenting with non-small 
cell lung cancer (NSCLC) is 70 years and the condition is rare in 
younger adults. NSCLC appears to have a different presentation and 
natural history in younger patients. 
Methods: The National Cancer Data Base (NCDB) is a cancer data-
base maintained by the American College of Surgeons. The NCDB data 
is obtained from the cancer programs participating in the Commission 
on Cancer NCDB annual call for data. Permission was obtained from 
the American College of Surgeons to access and analyze the data for 
publication. All patients diagnosed with NSCLC from 1998 to 2004 
were identiﬁed from the NCDB. The gender, race, stage and histology 
data were obtained from the NCDB. The characteristics of patients with 
NSCLC from 16-39 years of age were compared to the entire group. 
Results: A total of 657,982 patients with NSCLC were diagnosed from 
1998-2004. Only about 0.7% (4769) of these patients was under 40. We 
compared the characteristics of NSCLC in younger group to the entire 
cohort (Table). Younger patients were more likely to be women, 52 
% vs 42 % (p<0.001), and more likely to present with distant disease 
(stage 3 & 4) 74 % vs 60 % (p<0.001). Adenocarcinoma was more 
common in younger patients, 46 % vs. 37 %. Squamous cell carcinoma 
was far less common in younger patients, 12 % vs 27 % (p<0.001). 
Conclusions: Patients with NSCLC who are < 40 years old at diagno-
sis are more likely to be women and have adenocarcinoma and far less 
likely to have squamous cell carcinoma. Thus it appears that NSCLC in 
patients <40 years are biologically different.
<40  % All Patients %
Total Number 4769  657982  
Gender 
 Male 2287 48.0 380645 57.9
 Female 2482 52.0 277337 42.1
Race 
 White 3502 73.4 554147 84.2
 Black 715 15.0 68427 10.4
 Asian 194 4.1 10652 1.6
 Other 358 7.5 24756 3.8
Stage 
